Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Clinical Ophthalmology (Auckland, N.Z.)|September 8, 2016
Wide-field laser ophthalmoscopy for imaging of gas-filled eyes after macular hole surgeryShintaro Nakao, Ryoichi Arita, Yuki Sato, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 12, 2012
Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1Elliott H Sohn, Shikun He, Leo A Kim, et al.
JAMA Ophthalmology|April 23, 2026
Brolucizumab in the Treatment of Proliferative Diabetic Retinopathy: The CONDOR Randomized Clinical TrialSebastian Wolf, Youxin Chen, Xiaorong Li, et al.
Plos One|May 12, 2011
Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularizationHani Salehi-Had, Mi In Roh, Andrea Giani, et al.
JAMA Ophthalmology|May 6, 2021
Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical TrialAdam R Glassman, Wesley T Beaulieu, Maureen G Maguire, et al.
NEJM Evidence|April 22, 2025
Safety and Efficacy of Senolytic UBX1325 in Diabetic Macular EdemaSharon Klier, Jamie Dananberg, Lauren Masaki, et al.
Retina (Philadelphia, Pa.)|October 1, 2019
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical TrialsNeil M Bressler, Wesley T Beaulieu, Susan B Bressler, et al.
JAMA Ophthalmology|November 12, 2017
Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical TrialRaj K Maturi, Adam R Glassman, Danni Liu, et al.
JAMA|December 15, 2020
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical TrialAndrew N Antoszyk, Adam R Glassman, Wesley T Beaulieu, et al.
JAMA Ophthalmology|March 30, 2021
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical TrialRaj K Maturi, Adam R Glassman, Kristin Josic, et al.
Pageof 4